Results 21 to 30 of about 15,403 (196)

Irbesartan improves arterial compliance more than lisinopril

open access: yes, 2009
Khalid Ali,1 Chakravarthi Rajkumar,1 Francesco Fantin,2 Rebekah Schiff,3 Christopher J Bulpitt31Academic Department of Geriatrics, Brighton and Sussex Medical School, Brighton, UK; 2Department of Geriatrics, University of Verona, Italy; 3Section of ...
Khalid Ali   +10 more
core   +2 more sources

Assessment of Lisinopril Anti-Inflammatory Effect in Albino Rats [PDF]

open access: yesInternational Journal of Medical Arts, 2023
Background: Renin-angiotensin-aldosterone system produces the hormone angiotensin II (Ang II). Vascular tension is regulated, pro-inflammatory cytokines are released, nuclear factor kappa B is activated, oxidative stress is increased, and angiotensin-II ...
Hanan Alfiky
doaj   +1 more source

Study of Lisinopril in Heart Failure Patients

open access: yes, 2023
Heart failure is a progressive clinical syndrome that results in structural or functional abnormalities of the heart that disrupt the heart’s performance in pumping blood. The clinical manifestations are shortness of breath and cardiomegaly.
Hasmono, Didik   +3 more
core   +1 more source

Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line

open access: yesFrontiers in Pharmacology, 2022
The cellular mechanisms involved in myocardial ischemia/reperfusion injury (I/R) pathogenesis are complex but attributable to reactive oxygen species (ROS) production.
Lucia Scisciola   +7 more
doaj   +1 more source

The effect of swimming exercise on adenine-induced kidney disease in rats, and the influence of curcumin or lisinopril thereon. [PDF]

open access: yesPLoS ONE, 2017
Patients with chronic kidney disease (CKD) have been reported to benefit from different types of exercises. It has also been shown that the ACE inhibitor lisinopril, and the natural product curcumin are also beneficial in different models of CKD in rats.
Badreldin H Ali   +6 more
doaj   +1 more source

Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure

open access: yesFrontiers in Physiology, 2021
Recently, we reported that obese Dahl salt-sensitive leptin receptor mutant (SSLepRmutant) rats develop glomerular injury and progressive proteinuria prior to puberty. Moreover, this early progression of proteinuria was associated with elevations in GFR.
Andrea K. Brown   +9 more
doaj   +1 more source

ASSESSMENT OF INFLUENCE OF BETAGISTIN IN COMBINATION WITH ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE AND NEUROLOGICAL STATUS OF PATIENTS WITH STABLE ARTERIAL HYPERTENSION AND DIZZINESS

open access: yesРациональная фармакотерапия в кардиологии, 2015
More than a half of patients with stable mild to moderate arterial hypertension (AH) have dizziness. Rather often these patients need to take drugs, reducing blood pressure (BP) in combination with those, reducing intensity of dizziness. As patients with
G. V. Andreeva   +5 more
doaj   +3 more sources

New-Onset Acute Heart Failure With Reduced Ejection Fraction Associated With Severe Microcytic Anemia. [PDF]

open access: yesClin Case Rep
Graphical abstract summarizing a case of new‐onset HFrEF associated with profound microcytic anemia, highlighting severe anemia as a potential reversible trigger of acute cardiac decompensation. ABSTRACT Severe microcytic anemia may serve as a potentially reversible precipitating factor in heart failure with reduced ejection fraction (HFrEF). This case
Ricci A   +5 more
europepmc   +2 more sources

Anti-inflammatory activity of lisinopril in albino rats

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2018
Background: Angiotensin II (Ang II) is a product of renin angiotensin aldosterone system. Angiotensin‑II regulates vascular tone, stimulates the release of pro‑inflammatory cytokines, activates nuclear factor‑kappa B, increases oxidant ...
Siddamma Amoghimath, Suresha R N
doaj   +1 more source

Radiation Increases Bioavailability of Lisinopril, a Mitigator of Radiation-Induced Toxicities

open access: yesFrontiers in Pharmacology, 2021
There are no FDA-approved drugs to mitigate the delayed effects of radiation exposure that may occur after a radiological attack or nuclear accident.
Meetha Medhora   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy